Saxenda -Aus (Liraglutide PFS) 6mg/ml

Saxenda (Liraglutide 6mg/ml) is a prescription injectable pen for weight management in adults with obesity or weight-related conditions. This 5-pen pack is designed for daily subcutaneous use under medical supervision. Store between 2–8°C and protect from light. Always follow healthcare provider guidance.

Strength

6mg/ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Novo Nordisk Pharmaceuticals Pty Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Liraglutide 6mg/ml is prescribed to support weight loss in adults with a BMI of 30+ or 27+ with weight-related conditions like high blood pressure or type 2 diabetes. It works by regulating appetite and slowing digestion. This form is intended for people who need medical supervision during weight management. Commonly asked, what is Saxenda used for includes long-term weight control alongside diet and exercise.

Side Effects

Users may notice reduced hunger and earlier feelings of fullness after meals while using Liraglutide 6mg/ml. Some people experience mild nausea or digestive changes as the body adjusts. These effects often lessen over time. The 6mg/ml strength is formulated for consistent daily dosing to support weight management goals.

Precautions & Warnings

Keep Saxenda pens refrigerated between 2–8°C and use within 30 days after first use. Do not freeze or expose to heat. Rotate injection sites to avoid irritation. Discard pens after the expiration date or if the liquid appears cloudy. Always use a new needle for each injection and follow proper disposal guidelines.

Avoid Interactions

Liraglutide may interact with oral medications that require rapid absorption, such as antibiotics or pain relievers. Alcohol can increase the risk of side effects like dizziness or nausea. Some diabetes medications may require dose adjustments. Always inform your healthcare provider about all medications and supplements you are taking before starting Saxenda.

Frequently Asked Questions

Saxenda (Liraglutide 6mg/ml) is used to support weight loss in adults with obesity or weight-related conditions under medical supervision.

Store Saxenda pens refrigerated between 2–8°C and use within 30 days after first use. Do not freeze or expose to heat.

No, Saxenda is a prescription medication and should only be obtained with a valid prescription from a healthcare provider.

Common effects may include nausea, diarrhea, or constipation, especially when first starting treatment.

Saxenda is typically injected once daily under the skin (subcutaneous) as prescribed by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.